Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Reducing the risk of contracting COVID-19 in patients with NSCLC (IT)

Dr Giuseppe Giaccone, Dr Neal Navani, Professor Eric Lim
Reducing the risk of contracting COVID-19 in patients with NSCLC (IT) ( Dr Giuseppe Giaccone, Dr Neal Navani, Professor Eric Lim )
2 Mar 2021

Reducing the risk of contracting COVID-19 in patients with NSCLC (ES)

Dr Giuseppe Giaccone, Dr Neal Navani, Professor Eric Lim
Reducing the risk of contracting COVID-19 in patients with NSCLC (ES) ( Dr Giuseppe Giaccone, Dr Neal Navani, Professor Eric Lim )
2 Mar 2021

Cabozantinib most effective treatment for metastatic papillary kidney cancer

Dr Sumanta Pal - City of Hope, Duarte, USA
Cabozantinib most effective treatment for metastatic papillary kidney cancer ( Dr Sumanta Pal - City of Hope, Duarte, USA )
26 Feb 2021

Oral HIF-2 α inhibitor MK-6482 in patients with advanced clear cell renal cell carcinoma

Dr Todd Michael Bauer - Sarah Cannon Research Institute and Tennessee Oncology, Nashville, USA
Oral HIF-2 α inhibitor MK-6482 in patients with advanced clear cell renal cell carcinoma ( Dr Todd Michael Bauer - Sarah Cannon Research Institute and Tennessee Oncology, Nashville, USA )
26 Feb 2021

New tools that can be used in clinical practice to make better decisions for women with early breast cancer

Prof Martine Piccart - Université Libre de Bruxelles, Brussels, Belgium
New tools that can be used in clinical practice to make better decisions for women with early breast cancer ( Prof Martine Piccart - Université Libre de Bruxelles, Brussels, Belgium )
25 Feb 2021

SEMS trial: result of a prospective, multi-institutional phase II clinical trial of surgery in early metastatic seminoma

Dr Sia Daneshmand - University of Southern California, Los Angeles, USA
SEMS trial: result of a prospective, multi-institutional phase II clinical trial of surgery in early metastatic seminoma ( Dr Sia Daneshmand - University of Southern California, Los Angeles, USA )
24 Feb 2021

Sequencing endocrine treatment in metastatic luminal breast cancer and alpelisib for treatment of metastatic BC

Prof Hope Rugo - University of California San Francisco, San Francisco, USA
Sequencing endocrine treatment in metastatic luminal breast cancer and alpelisib for treatment of metastatic BC ( Prof Hope Rugo - University of California San Francisco, San Francisco, USA )
24 Feb 2021

Challenges in nursing GU cancer patients during COVID-19

Louisa Fleure - Guy's and St Thomas' NHS Trust, London, UK
Challenges in nursing GU cancer patients during COVID-19 ( Louisa Fleure - Guy's and St Thomas' NHS Trust, London, UK )
24 Feb 2021

Re-irradiation in breast cancer

Prof Philip Poortmans - University of Antwerp, Antwerp, Belgium
Re-irradiation in breast cancer ( Prof Philip Poortmans - University of Antwerp, Antwerp, Belgium )
19 Feb 2021

Postmastectomy radiation therapy in breast cancer patients who had immediate reconstruction

Prof Philip Poortmans - University of Antwerp, Antwerp, Belgium
Postmastectomy radiation therapy in breast cancer patients who had immediate reconstruction ( Prof Philip Poortmans - University of Antwerp, Antwerp, Belgium )
19 Feb 2021

Current treatment standards for primary ovarian cancer

Prof Robert Coleman - MD Anderson Cancer Center, Houston, USA
Current treatment standards for primary ovarian cancer ( Prof Robert Coleman - MD Anderson Cancer Center, Houston, USA )
18 Feb 2021

Evolving medical treatment in advanced/recurrent endometrial cancer

Prof Robert Coleman - MD Anderson Cancer Center, Houston, USA
Evolving medical treatment in advanced/recurrent endometrial cancer ( Prof Robert Coleman - MD Anderson Cancer Center, Houston, USA )
18 Feb 2021